InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Quart Barry D, Chief Executive Officer. Director active across 1 companies, notably Heron Therapeutics, INC.. Cumulatively, 7 reports have been logged. The latest transaction was filed on 30 April 2021 — J. Regulator: SEC (Form 4). All data is free.
Declarations7 total
3,646 shares
Common Stock
SEC:0001209191-22-024522:0·
3,646 shares
Common Stock
SEC:0001209191-22-003362·
3,646 shares
Common Stock
SEC:0001209191-22-003362:0·
3,646 shares
Common Stock
SEC:0001209191-21-060551·
3,646 shares
Common Stock
SEC:0001209191-21-060551:0·
€17,5221,529 shares@ €11.45990.0072% mcap100.0% of flow
Common Stock
SEC:0001209191-21-046790·
€17,5221,529 shares@ €11.45990.0072% mcap50.0% of flow
Common Stock
SEC:0001209191-21-046790:0·
7 of 7 declarations
About Quart Barry D
Barry D. Quart serves as Chief Executive Officer at HERON THERAPEUTICS, INC. /DE/. In this role, he is responsible for the strategic and operational leadership of the company. His expertise in management and business development enables him to guide HERON towards sustainable growth and continuous innovation. He collaborates closely with the management team to achieve the company's objectives.
